Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C H Yang

Showing results (681-690 of 738) with videos related to

Pageof 74
Sort By:
JMIR Serious Games|November 23, 2021
Using a 360° Virtual Reality or 2D Video to Learn History Taking and Physical Examination Skills for Undergraduate Medical Students: Pilot Randomized Controlled TrialYi-Ping Chao, Hai-Hua Chuang, Li-Jen Hsin, et al.
The Lancet. Respiratory Medicine|January 20, 2020
Safety and efficacy of nazartinib (EGF816) in adults with EGFR-mutant non-small-cell lung carcinoma: a multicentre, open-label, phase 1 studyDaniel S-W Tan, Natasha B Leighl, Gregory J Riely, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 31, 2006
Living donor liver transplantation for biliary atresia: a single-center experience with first 100 casesC-L Chen, A Concejero, C-C Wang, et al.
Clinical and Experimental Immunology|April 26, 2008
The role of a nuclear protein, histone H1, on signalling pathways for the maturation of dendritic cellsL W Hsu, C L Chen, T Nakano, et al.
BMC Cancer|June 7, 2022
Rationale and design of ON-TRK: a novel prospective non-interventional study in patients with TRK fusion cancer treated with larotrectinibJames C H Yang, Marcia S Brose, Gilberto Castro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 26, 2017
Osimertinib As First-Line Treatment of EGFR Mutation-Positive Advanced Non-Small-Cell Lung CancerSuresh S Ramalingam, James C-H Yang, Chee Khoon Lee, et al.
Nature|April 17, 2020
Operation of a silicon quantum processor unit cell above one kelvinC H Yang, R C C Leon, J C C Hwang, et al.
Alimentary Pharmacology & Therapeutics|November 10, 2011
Randomised clinical trial: a comparative study of 10-day sequential therapy with 7-day standard triple therapy for Helicobacter pylori infection in naïve patientsH G Park, M K Jung, J T Jung, et al.
Nature Communications|February 13, 2020
Coherent spin control of s-, p-, d- and f-electrons in a silicon quantum dotR C C Leon, C H Yang, J C C Hwang, et al.
Lung Cancer (Amsterdam, Netherlands)|February 9, 2025
Efficacy and safety of brigatinib in patients with ALK TKI-naive advanced ALK+ NSCLC: Integrated analysis of the ALTA-1L and J-ALTA trialsD Ross Camidge, Shunichi Sugawara, Masashi Kondo, et al.
Pageof 74

Showing results (681-690 of 738) with videos related to

Sort By:
Pageof 74
JMIR Serious Games|November 23, 2021
Using a 360° Virtual Reality or 2D Video to Learn History Taking and Physical Examination Skills for Undergraduate Medical Students: Pilot Randomized Controlled TrialYi-Ping Chao, Hai-Hua Chuang, Li-Jen Hsin, et al.
The Lancet. Respiratory Medicine|January 20, 2020
Safety and efficacy of nazartinib (EGF816) in adults with EGFR-mutant non-small-cell lung carcinoma: a multicentre, open-label, phase 1 studyDaniel S-W Tan, Natasha B Leighl, Gregory J Riely, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 31, 2006
Living donor liver transplantation for biliary atresia: a single-center experience with first 100 casesC-L Chen, A Concejero, C-C Wang, et al.
Clinical and Experimental Immunology|April 26, 2008
The role of a nuclear protein, histone H1, on signalling pathways for the maturation of dendritic cellsL W Hsu, C L Chen, T Nakano, et al.
BMC Cancer|June 7, 2022
Rationale and design of ON-TRK: a novel prospective non-interventional study in patients with TRK fusion cancer treated with larotrectinibJames C H Yang, Marcia S Brose, Gilberto Castro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 26, 2017
Osimertinib As First-Line Treatment of EGFR Mutation-Positive Advanced Non-Small-Cell Lung CancerSuresh S Ramalingam, James C-H Yang, Chee Khoon Lee, et al.
Nature|April 17, 2020
Operation of a silicon quantum processor unit cell above one kelvinC H Yang, R C C Leon, J C C Hwang, et al.
Alimentary Pharmacology & Therapeutics|November 10, 2011
Randomised clinical trial: a comparative study of 10-day sequential therapy with 7-day standard triple therapy for Helicobacter pylori infection in naïve patientsH G Park, M K Jung, J T Jung, et al.
Nature Communications|February 13, 2020
Coherent spin control of s-, p-, d- and f-electrons in a silicon quantum dotR C C Leon, C H Yang, J C C Hwang, et al.
Lung Cancer (Amsterdam, Netherlands)|February 9, 2025
Efficacy and safety of brigatinib in patients with ALK TKI-naive advanced ALK+ NSCLC: Integrated analysis of the ALTA-1L and J-ALTA trialsD Ross Camidge, Shunichi Sugawara, Masashi Kondo, et al.
Pageof 74